- Federal health executive Diana Ceban steps into the chief growth officer role at Tria Federal
- Her mandate centers on the cost-quality-access balance in federal health
- The 2026 Healthcare Summit will explore AI governance, federal health IT and more
Tria Federal has promoted Diana Ceban, a two-decade veteran of federal health markets and government contracting, to chief growth officer, a role in which she will direct the company’s enterprise growth strategy, business development and client and partner relationships.
In a statement published Thursday, Tria Federal CEO Tim Borchert said Ceban’s new role reflects the clarity that the company’s focus on balancing cost, quality and access to care has brought to its growth approach.
Federal health agencies continue to weigh how to control costs while maintaining quality and expanding access to care. Senior officials and industry executives will meet at the Potomac Officers Club’s 2026 Healthcare Summit on Dec. 3 to discuss those priorities, with Borchert scheduled to join a panel on balancing cost, quality and access in federal health delivery. The Tria Federal-backed event will also feature discussions on AI governance and the role of policy expertise, federal health IT modernization, and more. Register now to join the conversation.
“The trilemma has sharpened our focus as a company, and Diana will make sure we can move the needle on cost, quality, or access for the agencies we serve,” Borchert said. “Her leadership will be instrumental as we pursue our vision to make federal health systems work at national scale.”
What Are Ceban’s Responsibilities as Chief Growth Officer?
In her new position, Ceban will oversee Tria Federal’s pipeline and pursuits across its federal health business, with a focus on helping agency clients address the competing pressures of cost, quality and access to care. Her portfolio includes market expansion, business development and the company’s relationships with clients and partners.
Ceban will also work alongside Tria’s public safety business to pursue contracts that apply the company’s technical and health-related expertise to public safety and national security missions, including work with the Department of Homeland Security and the Department of War.
Who Is Diana Ceban?
Ceban is a federal health executive who joined Tria Federal in 2024 as executive vice president for military and veteran health. She was promoted in 2025 to EVP for strategic initiatives and market expansion, a role in which she strengthened the company’s client and partner ties and positioned it for new market pursuits.
Before joining Tria, Ceban served as VP and health market leader at SAIC, where she led a division supporting the Department of Veterans Affairs, the Military Health System and the Department of Health and Human Services.
Ceban also served as business development manager at Optimal Solutions & Technologies, where she worked with healthcare agencies within HHS, VA and the Defense Health Agency, according to her LinkedIn profile.
She was also a business development manager at Digicon and USIS and served as a client services manager at Deltek for nearly four years.
“Growth in federal health isn’t about chasing the next contract; it’s about understanding the whole operating system deeply enough to know where meaningful gains are possible in order to further the missions we support,” Ceban said. “At the scale our federal health customers operate, even a one percent improvement in an aspect of the trilemma, while holding steady in the other areas, can generate real outcomes that compound over time. My focus as chief growth officer is making sure we foster growth where that kind of impact is possible.”
How Does the Promotion Align With Tria’s Growth Strategy?
The move follows Tria’s earlier appointment of business development executive Sean Vineyard as senior VP of growth operations, tasked with leading enterprise business development and executing the company’s capture strategy. Tria has also continued building out its growth ranks, recently adding three new leaders to its business development team to support its expanding federal health mission work.
These moves come alongside notable contract momentum, including a five-year, $174 million recompete win with the VA’s Financial Services Center secured through Tria subsidiary Softrams.
